Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inspire Medical Systems (INSP) EPS (Basic) (2017 - 2026)

Inspire Medical Systems' EPS (Basic) history spans 10 years, with the latest figure at -$0.39 for Q1 2026.

  • On a quarterly basis, EPS (Basic) fell 490.0% to -$0.39 in Q1 2026 year-over-year; TTM through Mar 2026 was $4.46, a 99.11% increase, with the full-year FY2025 number at $4.95, up 175.0% from a year prior.
  • EPS (Basic) hit -$0.39 in Q1 2026 for Inspire Medical Systems, down from $4.63 in the prior quarter.
  • Over the last five years, EPS (Basic) for INSP hit a ceiling of $4.63 in Q4 2025 and a floor of -$0.61 in Q1 2022.
  • Historically, EPS (Basic) has averaged $0.24 across 5 years, with a median of -$0.12 in 2025.
  • Biggest five-year swings in EPS (Basic): skyrocketed 313.79% in 2024 and later tumbled 490.0% in 2026.
  • Tracing INSP's EPS (Basic) over 5 years: stood at $0.13 in 2022, then surged by 292.31% to $0.51 in 2023, then surged by 133.33% to $1.19 in 2024, then soared by 289.08% to $4.63 in 2025, then tumbled by 108.42% to -$0.39 in 2026.
  • Business Quant data shows EPS (Basic) for INSP at -$0.39 in Q1 2026, $4.63 in Q4 2025, and $0.34 in Q3 2025.